Patent · US Expired

Use of 1H-indol-3-yl-2-oxoacetamide compounds

US7396838B2 · kind B2 · utility

0Cited by
9References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 6, 2005
Grant dateJul 8, 2008
Priority date
Expiry dateAug 30, 2025

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A method of treating cancer including administering to a subject in need thereof an effective amount of a compound of the formula 1:wherein R1, R2, R3, R4, and n are as defined herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.